Stéphane Dalle Selected Research

Panniculitis

1/2022	Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.
4/2013	Vemurafenib-induced panniculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stéphane Dalle Research Topics

Disease

54	Melanoma (Melanoma, Malignant) 10/2022 - 02/2006
27	Neoplasms (Cancer) 08/2022 - 02/2006
10	Type 2 Diabetes Mellitus (MODY) 04/2022 - 02/2002
6	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2016
5	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022 - 03/2014
4	Obesity 01/2022 - 10/2014
4	Insulin Resistance 10/2019 - 02/2013
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018 - 02/2007
4	Lymphoma (Lymphomas) 01/2016 - 01/2006
3	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2004
3	Lymphatic Metastasis 11/2020 - 03/2016
2	Panniculitis 01/2022 - 04/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2015
2	Diabetes Mellitus 12/2019 - 04/2019
2	Hyperglycemia 10/2019 - 01/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019 - 04/2019
2	Pure Red-Cell Aplasia 01/2019 - 01/2019
2	Mycosis Fungoides 03/2014 - 01/2008
1	Autoimmune Diseases (Autoimmune Disease) 10/2022
1	Inflammation (Inflammations) 04/2022
1	Vasculitis (Vasculitides) 01/2022
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 01/2022
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022
1	Lipodystrophy 01/2022
1	Cardiotoxicity 01/2022
1	Pancreatitis 01/2022
1	Symptom Flare Up 01/2021
1	Weight Gain 01/2021
1	Viremia 01/2021
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 11/2020
1	Hypophysitis 10/2020
1	Autoimmune Pancreatitis 12/2019
1	Non-alcoholic Fatty Liver Disease 10/2019
1	Hypertriglyceridemia 10/2019
1	Ketosis 04/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 01/2019
1	Insulinoma 01/2019
1	Dermatomyositis (Dermatopolymyositis) 11/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 05/2018

Drug/Important Bio-Agent (IBA)

15	pembrolizumabIBA 01/2022 - 02/2017
11	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2016
9	IpilimumabIBA 10/2021 - 09/2012
8	NivolumabIBA 01/2022 - 11/2017
6	Rituximab (Mabthera)FDA Link 01/2018 - 02/2007
5	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2008
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2007
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2017
5	Insulin (Novolin)FDA Link 01/2021 - 07/2006
5	VemurafenibIBA 05/2017 - 10/2011
4	CytokinesIBA 04/2022 - 03/2016
4	Monoclonal AntibodiesIBA 01/2022 - 05/2009
4	B7-H1 AntigenIBA 11/2020 - 11/2019
3	AntibodiesIBA 10/2019 - 01/2014
3	Glucose (Dextrose)FDA LinkGeneric 10/2014 - 03/2011
3	glucagon (19-29)IBA 10/2014 - 02/2002
3	Peptides (Polypeptides)IBA 10/2014 - 02/2002
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2021
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 10/2020
2	mogamulizumabIBA 01/2022 - 01/2021
2	Zinc Finger E-box-Binding Homeobox 1IBA 01/2022 - 10/2016
2	CateninsIBA 01/2022 - 01/2022
2	AutoantibodiesIBA 01/2022 - 04/2019
2	InterferonsIBA 01/2022 - 01/2008
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2016
2	Chemokine ReceptorsIBA 08/2016 - 03/2016
2	Glucagon-Like Peptide-1 ReceptorIBA 05/2016 - 01/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 01/2006
2	Glucagon (Glukagon)FDA Link 10/2014 - 02/2005
2	Bexarotene (LGD1069)FDA Link 06/2014 - 01/2008
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2014 - 02/2013
2	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2014 - 02/2013
2	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2012 - 07/2008
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Perilipin-1IBA 01/2022
1	SteroidsIBA 01/2022
1	relatlimabIBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	IntegrinsIBA 10/2021
1	GlucocorticoidsIBA 05/2021
1	Vorinostat FDA Link 01/2021
1	Transcription Factors (Transcription Factor)IBA 08/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	EnzymesIBA 01/2020
1	cyclopropapyrroloindoleIBA 12/2019
1	LeptinIBA 10/2019
1	ArrestinIBA 01/2019
1	Ectodysplasin ReceptorsIBA 01/2019
1	ArrestinsIBA 01/2019
1	Acid CeramidaseIBA 01/2019
1	SphingolipidsIBA 01/2019

Therapy/Procedure

30	Therapeutics 01/2022 - 02/2006
8	Immunotherapy 08/2022 - 01/2016
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2022 - 03/2009
3	Radiotherapy 01/2019 - 01/2004
2	Combination Drug Therapy (Combination Chemotherapy) 01/2018 - 05/2014